ForbesThis Startup Has a New CRISPR Enzyme – And Says It Will Give It Away For FreeForbesCRISPR, short for Clustered Regularly Interspaced Short Palindromic Repeats, refers to repeated patterns seen in bacterial DNA. Microbes use them as part of an imm… Continue reading
DesignNewsSmart Hydrogels Eyed for Targeted Drug Delivery, Stem-Cell TherapyDesignNewsHydrogels are also known as “soft matter” in the medical field, and researchers see them as materials that will lead next-generation applications in drug delivery and… Continue reading
Technology NetworksSearching for the CRISPR Swiss-army KnifeTechnology NetworksSearching for the CRISPR Swiss-army Knife. News Dec 13, 2017 | Original story from FECYT – Spanish Foundation for Science and Technology. Searching for the CRISPR Swiss-army… Continue reading
ABS-CBN NewsThe Medical City offers bone marrow and stem cell transplantABS-CBN NewsThe Institute of Personalized Molecular Medicine (IPMM) of premier health institution The Medical City (TMC) offers bone marrow and stem cell transplantation which have… Continue reading
YourStory.comStem cell startup Advancells scales to Rs 10 crore revenue in 4 yearsYourStory.comVipul Jain, who believes stem cells are the future of healthcare, is focused on making Advancells a therapy provider even as most Indian companies concentrat… Continue reading
Daily PressW&M team wins first runner-up in synthetic biology competitionDaily PressTheir project to control the speed of gene expression was a standout among hundreds of submissions from major institutions competing in Boston last month in the … Continue reading
Scicasts (press release) (blog)Searching for the CRISPR Swiss Army knifeScicasts (press release) (blog)Madrid, Spain (Scicasts) — Scientists at the University of Copenhagen, led by the Spanish Professor Guillermo Montoya, are investigating the molecula… Continue reading
|
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Science Daily “Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need,” said Dr. Leslie Kean, the trial’s principal investigator and associate director of the Ben Towne … |